About the VP
Stephen M. Lanier has been the Vice President for Research at Wayne State University since June 16, 2014. He received his doctorate in pharmacology from the University of Tennessee Center for Health Sciences and received postdoctoral training in the laboratory of Charles Homcy and Robert Graham at Harvard Medical School in the Cardiac Unit at Massachusetts General Hospital under the direction of Edgar Haber. SML was appointed as an Assistant Professor in the Department of Medicine, Harvard Medical School and continued his research in the Cardiac Unit at Massachusetts General Hospital. In 1991, he was recruited to the Department of Cell and Molecular Pharmacology and Experimental Therapeutics at the Medical University of South Carolina (MUSC). Dr. Lanier accepted the position of Chair of the Department of Pharmacology at Louisiana State University Health Sciences Center in New Orleans in March 2001. He has served as the Chief Scientific Officer, Associate Provost for Research and Professor of Pharmacology at the Medical University of South Carolina since December 1, 2006.
Dr. Lanier has served on multiple review panels for the National Institutes of Health and other scientific panels, provided leadership for professional organizations, established international collaborative partnerships, served as Chair and Organizer of scientific conferences, and consulted for a number of larger pharmaceutical concerns and biotechnology firms over the years. He has served on editorial boards for leading scientific journals and served as Director of Institutional Training Grants and two Centers of Biomedical Research Excellence. Dr. Lanier has trained over 40 fellows/students whom are pursuing careers in biomedical research around the world.
For the past six years, Dr. Lanier served as the Chief Scientific Officer and Institutional Official for Research at the Medical University of South Carolina responsible for the research enterprise in its broadest sense encompassing a range of regulatory affairs and policy development as indicated in the attached vitae. In his capacity as the Chief Institutional Research Officer at the Medical University of South Carolina, he retooled research support operations, augmented entrepreneurial initiatives, overseen the development of new research buildings and nurtured sustained growth in extramural funding ($232M – FY13). Activities include significant program collaboration and partnerships in health care and biomedical research involving the public and private sector.
Dr. Lanier is recognized as a leading, creative investigator in the area of cell signaling and signal integration in health and disease. His research has led to the development of new concepts in the field of cell signaling and has resulted in the generation of a number of tools and resources that are widely used in the research community.